Predicted preferences for changes to elements of the current guidelines, in the event that resistance to SP leads to worse health outcomes.

aUnder this scenario, the clinical guidelines for treatment remain the same as currently defined, but resistance to SP would lead to worse health outcomes: 15% incidence of low birth weight and 15% incidence of severe anaemia.bUnder this scenario, the clinical guidelines for treatment remain the same as currently defined, but resistance to SP would lead to worse health outcomes: 13% incidence of low birth weight and 5% incidence of severe anaemia.cUnder all scenarios of policy 2, the health outcomes are 10% incidence of low birth weight and 1% incidence of severe anaemia.a. 在此场景下，临床治疗指南仍与当前既定版本一致，但对SP（SP）产生耐药性将导致更差的健康结局：低出生体重发生率为15%，重度贫血发生率为15%。 b. 在此场景下，临床治疗指南仍与当前既定版本一致，但对SP产生耐药性将导致更差的健康结局：低出生体重发生率为13%，重度贫血发生率为5%。 c. 在政策2的所有场景中，健康结局为低出生体重发生率10%，重度贫血发生率1%。